Leading the Way: Life Sciences and Competitiveness
In today's rapidly evolving landscape of innovation and scientific advancement, the life sciences sector, compassing both private and public domains, finds itself at a pivotal juncture. This crossroads presents both immense opportunities and significant challenges.
Suzanne Håkansson, Senior Director Corporate Affairs, AstraZeneca
To remain competitive, our field must prioritize access to cutting-edge medical research and technologies, operate in environments that facilitate swift and decisive action, and cultivate a culture where innovation is not only welcomed but also effectively implemented.
